Partially Autonomous Information System Facilitating Performance-based Managed Entry Agreements in Slovakia
- Resource Type
- Conference
- Authors
- Tichopad, Ales
- Source
- 2022 E-Health and Bioengineering Conference (EHB) E-Health and Bioengineering Conference (EHB), 2022. :1-4 Nov, 2022
- Subject
- Bioengineering
Communication, Networking and Broadcast Technologies
Components, Circuits, Devices and Systems
Computing and Processing
Engineered Materials, Dielectrics and Plasmas
Fields, Waves and Electromagnetics
Signal Processing and Analysis
Drugs
Privacy
Regulators
Force
Medical treatment
Legislation
Europe
managed entry agreements
PGP
drug market access
e-health
- Language
- ISSN
- 2575-5145
Performance-Based Managed Entry Agreements (PB MEAs) are agreements between payers and/or regulators on one and health technology businesses on the other end in which the individual patient's treatment success rate is monitored. Agreed reimbursement is determined by that rate. Without a successful response to treatment, reimbursement is reduced or completely absent. There is a high need for functional PB MEA systems across the developed economies. Satisfactory wide use has not yet been achieved. The reason is, among other things, technical obstacles and lack of adaptability of existing IT and data systems to the purpose of PB MEA. We present an autonomous cloud-based e-health information system to facilitate a transfer, data aggregation and analysis of real-world drug effectiveness data for the sake of PB MEA execution. The system makes use of a Pretty Good Privacy security feature for encrypting and decrypting and existing national e-health authentication cards.